[Preliminary Report on the Relations Between Toxoplasmosis, Lysergic Acid & Schizophrenia]
Overview
Authors
Affiliations
Grada S, Mihu A, Oatis D, Marc C, Chicea L, Petrescu C Biomedicines. 2024; 12(5).
PMID: 38790960 PMC: 11117935. DOI: 10.3390/biomedicines12050998.
A comprehensive assessment of toxoplasmosis and its dormant impact on psychotic disorders (Review).
Mares A, Varlam C, Iliuta F, Lacau R, Manea M Biomed Rep. 2024; 20(6):86.
PMID: 38665421 PMC: 11040222. DOI: 10.3892/br.2024.1774.
Ademe M, Kebede T, Teferra S, Alemayehu M, Girma F, Abebe T PLoS One. 2022; 17(6):e0270377.
PMID: 35737701 PMC: 9223392. DOI: 10.1371/journal.pone.0270377.
Toxoplasma gondii and schizophrenia: a review of published RCTs.
Chorlton S Parasitol Res. 2017; 116(7):1793-1799.
PMID: 28508166 DOI: 10.1007/s00436-017-5478-y.
Alvarado-Esquivel C, Alanis-Quinones O, Arreola-Valenzuela M, Rodriguez-Briones A, Piedra-Nevarez L, Duran-Morales E BMC Infect Dis. 2006; 6:178.
PMID: 17178002 PMC: 1764421. DOI: 10.1186/1471-2334-6-178.